Cannabinoid Encyclopedia

Focused research review

Anandamide: what the research says

What evidence defines anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms?

Updated July 2026 15 research sources Mostly early-stage research

The short answer

What is the bottom line?

Research has examined Anandamide. This page brings together 1 human-study source, 11 research reviews, and 3 lab, animal, or mechanism sources. Most of the current evidence is preclinical or focused on biological mechanisms. The studies do not all test the same product, dose, group of people, or outcome, so they cannot be reduced to one answer for every person or product. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about Anandamide.

What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Key takeaways

What to know first

  1. 1

    Research on Anandamide covers Anandamide biology, receptor pharmacology, metabolism, physiology, or safety-...; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What researchers studied about Anandamide

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Too limited for a firm answer

Anandamide biology, receptor pharmacology, metabolism, physiology, or safety-...

This part of the literature focuses on Anandamide biology, receptor pharmacology, metabolism, physiology, or safety-.... Studies may use different compounds, formulations, doses, routes, groups of people, and outcomes, so the details of each source matter. 2

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

1 source

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

11 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

3 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on Anandamide is not one kind of study. This source set includes 11 narrative or expert reviews, 2 animal studies, and 2 cell or laboratory studies. 3

The recorded populations or models include animal models (3 sources), cells or tissue models (2 sources), and people or patients (2 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms (15 sources). Closely related outcome names can still describe different measurements. 5

The Anandamide source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Amygdala FAAH and anandamide: mediating protection and recovery from stress.

On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 1

Study type
narrative or expert review
Outcome focus
anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

narrative or expert review

Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities.

On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 2

Study type
narrative or expert review
Outcome focus
anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

cell or laboratory study

The major endocannabinoid anandamide (AEA) induces apoptosis of human granulosa cells.

On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 3

Study type
cell or laboratory study
Population or model
people or patients
Outcome focus
anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
mechanism-focused research

narrative or expert review

Anandamide and its metabolites: what are their roles in the kidney?

On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 4

Study type
narrative or expert review
Outcome focus
anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

narrative or expert review

Anandamide receptors.

On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 5

Study type
narrative or expert review
Population or model
animal models
Outcome focus
anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on Anandamide should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What evidence defines anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms?

Relevant research is collected here. Most of the current evidence is preclinical or focused on biological mechanisms. 7

Why is there not always a yes-or-no answer?

The sources may test different products, doses, people, and outcomes, so a single conclusion can hide important differences. 8

Where can I read the original studies?

Use the numbered citations and the source list at the bottom of the page to open PubMed or DOI records. 9

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Amygdala FAAH and anandamide: mediating protection and recovery from stress. narrative or expert review; evidence still limited PubMed 24325918 DOI 10.1016/j.tips.2013.08.008
  2. 2
    Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. narrative or expert review; evidence still limited PubMed 36150527 DOI 10.1016/j.plipres.2022.101194
  3. 3
    The major endocannabinoid anandamide (AEA) induces apoptosis of human granulosa cells. cell or laboratory study; mechanism-focused research PubMed 34126378 DOI 10.1016/j.plefa.2021.102311
  4. 4
    Anandamide and its metabolites: what are their roles in the kidney? narrative or expert review; evidence still limited PubMed 27100705 DOI 10.2741/s461
  5. 5
    Anandamide receptors. narrative or expert review; evidence still limited PubMed 12052051 DOI 10.1054/plef.2001.0349
  6. 6
    Anandamide uptake explained? narrative or expert review; evidence still limited PubMed 22297258 DOI 10.1016/j.tips.2012.01.001
  7. 7
    Chemical probes of endocannabinoid metabolism. narrative or expert review; evidence still limited PubMed 23512546 DOI 10.1124/pr.112.006387
  8. 8
    Druggable Targets in Endocannabinoid Signaling. narrative or expert review; evidence still limited PubMed 32894511 DOI 10.1007/978-3-030-50621-6_8
  9. 9
    Endocannabinoid metabolism by cytochrome P450 monooxygenases. narrative or expert review; evidence still limited PubMed 25461979 DOI 10.1016/j.prostaglandins.2014.11.002
  10. 10
    Endocannabinoids and pregnancy. narrative or expert review; evidence still limited PubMed 20302856 DOI 10.1016/j.cca.2010.03.012
  11. 11
    Metabolism of endocannabinoids. narrative or expert review; evidence still limited PubMed 27516570 DOI 10.5604/17322693.1213898
  12. 12
    Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors. narrative or expert review; evidence still limited PubMed 32867595 DOI 10.1146/annurev-pharmtox-030220-112741
See all 15 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. narrative or expert review; evidence still limited / 1 linked research note PubMed 36150527
  2. Metabolism of endocannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 27516570
  3. Anandamide uptake explained? narrative or expert review; evidence still limited / 1 linked research note PubMed 22297258
  4. Anandamide receptors. narrative or expert review; evidence still limited / 1 linked research note PubMed 12052051
  5. The major endocannabinoid anandamide (AEA) induces apoptosis of human granulosa cells. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 34126378
  6. Endocannabinoid metabolism by cytochrome P450 monooxygenases. narrative or expert review; evidence still limited / 1 linked research note PubMed 25461979
  7. Endocannabinoids and pregnancy. narrative or expert review; evidence still limited / 1 linked research note PubMed 20302856
  8. Anandamide and its metabolites: what are their roles in the kidney? narrative or expert review; evidence still limited / 1 linked research note PubMed 27100705
  9. Endocannabinoids. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 35038882
  10. Cannabinoid CB1 receptors regulate salivation. animal study; mechanism-focused research / 1 linked research note PubMed 35986066
  11. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. animal study; mechanism-focused research / 1 linked research note PubMed 11470906
  12. Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors. narrative or expert review; evidence still limited / 1 linked research note PubMed 32867595
  13. Druggable Targets in Endocannabinoid Signaling. narrative or expert review; evidence still limited / 1 linked research note PubMed 32894511
  14. Chemical probes of endocannabinoid metabolism. narrative or expert review; evidence still limited / 1 linked research note PubMed 23512546
  15. Amygdala FAAH and anandamide: mediating protection and recovery from stress. narrative or expert review; evidence still limited / 1 linked research note PubMed 24325918